| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5673576 | Microbial Pathogenesis | 2017 | 35 Pages |
Abstract
Our results demonstrate that HSP70 enriched EXO is an effective immunoadjuvant in cancer immunotherapy and causes tumor regression in animal model.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Elham Behzadi, Hamideh Mahmoodzadeh Hosseini, Raheleh Halabian, Abbas Ali Imani Fooladi,